Merck looks to capitalise on growing medicine needs of China, which is set to become second-biggest drugs market behind US by 2016.
via IBTimes.co.uk : Articles by Jerin Mathew http://www.ibtimes.co.uk/articles/522552/20131115/merck-china-pharmaceutical-scandal-glaxosmithkline.htm November 15, 2013 at 11:35AM
via IBTimes.co.uk : Articles by Jerin Mathew http://www.ibtimes.co.uk/articles/522552/20131115/merck-china-pharmaceutical-scandal-glaxosmithkline.htm November 15, 2013 at 11:35AM
No comments:
Post a Comment